We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
+8.79%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$21.1B
AUM Growth
+$828M
Cap. Flow
-$358M
Cap. Flow %
-1.7%
Top 10 Hldgs %
10.93%
Holding
2,666
New
960
Increased
418
Reduced
406
Closed
754

Sector Composition

Rank Sector Weight
1 Technology 14.15%
2 Financials 13.1%
3 Healthcare 11.2%
4 Consumer Discretionary 11.13%
5 Industrials 10.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPEN icon
351
Opendoor
OPEN
$3.38B
$16.2M 0.08%
+944,389
New +$16.2M
WPC icon
352
W.P. Carey
WPC
$16.4B
$16.1M 0.08%
220,922
+72,286
+49% +$5.29M
HIBB
353
DELISTED
Hibbett, Inc. Common Stock
HIBB
$16.1M 0.08%
179,819
+151,685
+539% +$11.9M
NSA
354
DELISTED
National Storage Affiliates Trust
NSA
$16.1M 0.08%
+318,473
New +$14.6M
ECL icon
355
Ecolab
ECL
$79.9B
$16.1M 0.08%
+78,134
New +$17M
REXR icon
356
Rexford Industrial Realty
REXR
$8.19B
$16.1M 0.08%
281,842
-277,472
-50% -$15.4M
PWR icon
357
Quanta Services
PWR
$101B
$16M 0.08%
176,573
-17,245
-9% -$1.62M
RPD icon
358
Rapid7
RPD
$773M
$16M 0.08%
168,866
-106,660
-39% -$8.98M
COHR
359
PUT
DELISTED
Coherent Inc
COHR
$15.9M 0.08%
60,000
-6,900
-10% -$1.81M
IOVA icon
360
Iovance Biotherapeutics
IOVA
$2.87B
$15.8M 0.08%
609,124
+441,812
+264% +$11.5M
CVS icon
361
CVS Health
CVS
$122B
$15.8M 0.07%
189,649
+146,863
+343% +$12M
NTR icon
362
Nutrien
NTR
$30.7B
$15.8M 0.07%
260,813
-686,575
-72% -$40.6M
INTU icon
363
Intuit
INTU
$89B
$15.8M 0.07%
32,156
-142,593
-82% -$61.8M
NVO
364
Novo Nordisk
NVO
$209B
$15.7M 0.07%
+374,192
New +$14.5M
AIR icon
365
AAR Corp
AIR
$5.76B
$15.6M 0.07%
402,987
+295,878
+276% +$11.9M
HIG icon
366
CALL
Hartford Financial Services
HIG
$39.3B
$15.5M 0.07%
+250,000
New +$16.4M
WPM icon
367
Wheaton Precious Metals
WPM
$60.9B
$15.5M 0.07%
351,048
-142,621
-29% -$6.34M
NARI
368
DELISTED
Inari Medical, Inc. Common Stock
NARI
$15.4M 0.07%
165,627
+139,602
+536% +$13.5M
REGN icon
369
CALL
Regeneron Pharmaceuticals
REGN
$80.8B
$15.3M 0.07%
+27,400
New +$13.9M
FNF icon
370
Fidelity National Financial
FNF
$13.5B
$15.3M 0.07%
365,092
+123,944
+51% +$5.41M
EXEL icon
371
Exelixis
EXEL
$13.4B
$15.3M 0.07%
837,332
+158,661
+23% +$3.7M
NCLH icon
372
Norwegian Cruise Line
NCLH
$8.84B
$15.2M 0.07%
+516,378
New +$15.6M
IGV icon
373
iShares Expanded Tech-Software Sector ETF
IGV
$14.7B
$15.1M 0.07%
+193,905
New +$14.1M
PEN icon
374
Penumbra
PEN
$12.8B
$15.1M 0.07%
+55,190
New +$15.1M
HUBS icon
375
HubSpot
HUBS
$10.5B
$15.1M 0.07%
25,929
-33,196
-56% -$17.3M

Similar funds

Balyasny Asset Management's Q2 2021 Portfolio in Review

As of Q2 2021, Balyasny Asset Management held 2,666 positions worth $21.1B, up 4.1% from $20.3B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Balyasny Asset Management's Q2 2021 filing shows 960 new, 418 increased, 406 reduced and 754 closed positions. Its largest new stake was Nuance Communications, Inc.: 4,636,095 shares worth $252M. The largest sale was Bank of America, an estimated $169M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

  • Balyasny Asset Management's largest Q2 2021 buy was Nuance Communications, Inc.: 4,636,095 shares worth $252M.
  • Balyasny Asset Management added most to QTS REALTY TRUST, INC. in Q2 2021, an estimated $91.6M increase.
  • Balyasny Asset Management's biggest Q2 2021 reduction was Morgan Stanley, cutting an estimated $151M.
  • Balyasny Asset Management fully exited Bank of America in Q2 2021, selling an estimated $169M.
  • Balyasny Asset Management's ten largest holdings make up 11% of its $21.1B portfolio in Q2 2021.
  • Balyasny Asset Management opened 960 new positions and closed 754 in Q2 2021.
  • Balyasny Asset Management's portfolio value rose 4.1% quarter-over-quarter to $21.1B.

Based on Balyasny Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.